Kamfanin Co-kafa da Shugaba Dr. Eric Finzi ya ba da labaran duniya lokacin da ya buga gwaji na farko da ke nuna tasiri na botulinum toxin a cikin magance manyan cututtuka (MDD) a cikin 2006. Daga bisani, gwaje-gwaje na asibiti guda biyar na Phase II sun nuna tasirin botulinum toxin kamar yadda maganin bacin rai.
Kamfanin yana neman haɓaka haɓakar toxin botulinum azaman zaɓin magani na tabin hankali don baƙin ciki. Sama da Amurkawa miliyan 19 na fama da bakin ciki, inda aka kiyasta mutane miliyan 280 a duk duniya, a cewar Hukumar Lafiya ta Duniya (WHO). Ta hanyar yin niyya daban-daban hanyoyin neuromuscular fiye da jiyya na yanzu, Healis yana neman haɓaka sabbin hanyoyin zaɓuɓɓukan jiyya. A cikin karatun Phase II, ana allurar toxin botulinum a cikin yankin glabellar da tsokoki masu murtuke, gami da corrugator da procerus. Botulinum toxin ana tsammanin zai magance damuwa ta hanyar hanyar amsa fuska tsakanin maganganun tsokar fuska da kwakwalwa.
Botulinum toxin a halin yanzu an yarda da FDA don ciwon kai na yau da kullun, dystonia na mahaifa, da hyperhidrosis axillary, a tsakanin sauran alamun likita. Botulinum toxin yana karuwa a cikin magungunan zamani yana kan sama da shekaru ashirin da aka yi amfani da shi a masana'antar kwaskwarima.
Disclaimer: Tun daga 23 Disamba 2021, toxin botulinum ba maganin da aka amince da FDA ba don maganin babban rashin damuwa (MDD), baƙin ciki na bipolar, ko cuta ta tashin hankali (PTSD). Botulinum toxin don MDD, damuwa na bipolar, da PTSD suna ƙarƙashin amfani da bincike kawai kuma ba a samuwa don rarraba kasuwanci.
